{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:34:03Z","timestamp":1774899243178,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T00:00:00Z","timestamp":1326931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s12640-012-9309-8","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T02:53:32Z","timestamp":1326855212000},"page":"274-279","source":"Crossref","is-referenced-by-count":17,"title":["Nifedipine Prevents Iron Accumulation and Reverses Iron-Overload-Induced Dopamine Neuron Degeneration in the Substantia Nigra of Rats"],"prefix":"10.1007","volume":"22","author":[{"given":"ZeGang","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JunXia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,19]]},"reference":[{"key":"9309_CR1","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuint.2007.02.003","volume":"50","author":"V Anantharam","year":"2007","unstructured":"Anantharam V, Lehrmann E, Kanthasamy A, Yang Y, Banerjee P, Becker KG, Freed WJ, Kanthasamy AG (2007) Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson\u2019s disease. Neurochem Int 50:834\u2013847","journal-title":"Neurochem Int"},{"key":"9309_CR2","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","volume":"341","author":"NC Andrews","year":"1999","unstructured":"Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341:1986\u20131995","journal-title":"N Engl J Med"},{"key":"9309_CR3","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/mds.21020","volume":"21","author":"D Berg","year":"2006","unstructured":"Berg D, Hochstrasser H (2006) Iron metabolism in Parkinsonian syndromes. Mov Disord 21:1299\u20131310","journal-title":"Mov Disord"},{"key":"9309_CR4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","volume":"65","author":"D Blum","year":"2001","unstructured":"Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson\u2019s disease. Prog Neurobiol 65:135\u2013172","journal-title":"Prog Neurobiol"},{"key":"9309_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1997.69020443.x","volume":"69","author":"MW Bradbury","year":"1997","unstructured":"Bradbury MW (1997) Transport of iron in the blood\u2013brain\u2013cerebrospinal fluid system. J Neurochem 69:443\u2013454","journal-title":"J Neurochem"},{"key":"9309_CR6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","volume":"447","author":"CS Chan","year":"2007","unstructured":"Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE, Surmeier DJ (2007) \u2018Rejuvenation\u2019 protects neurons in mouse models of Parkinson\u2019s disease. Nature 447:1081\u20131086","journal-title":"Nature"},{"key":"9309_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4899-1775-1_2","volume":"4","author":"M Waard De","year":"1996","unstructured":"De Waard M, Gurnett CA, Campbell KP (1996) Structural and functional diversity of voltage-activated calcium channels. Ion Channels 4:41\u201387","journal-title":"Ion Channels"},{"key":"9309_CR8","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J Neurochem 52:1830\u20131836","journal-title":"J Neurochem"},{"key":"9309_CR9","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1471-4159.1993.tb03527.x","volume":"60","author":"BA Faucheux","year":"1993","unstructured":"Faucheux BA, Hirsch EC, Villares J, Selimi F, Mouatt-Prigent A, Javoy-Agid F, Hauw JJ, Agid Y (1993) Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson\u2019s disease. J Neurochem 60:2338\u20132341","journal-title":"J Neurochem"},{"key":"9309_CR10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","volume":"353","author":"BA Faucheux","year":"1999","unstructured":"Faucheux BA, Bonnet AM, Agid Y, Hirsch EC (1999) Blood vessels change in the mesencephalon of patients with Parkinson\u2019s disease. Lancet 353:981\u2013982","journal-title":"Lancet"},{"key":"9309_CR11","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1046\/j.1471-4159.2003.01923.x","volume":"86","author":"BA Faucheux","year":"2003","unstructured":"Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC (2003) Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson\u2019s disease. J Neurochem 86:1142\u20131148","journal-title":"J Neurochem"},{"key":"9309_CR12","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s11064-007-9313-1","volume":"32","author":"JA Gaasch","year":"2007","unstructured":"Gaasch JA, Geldenhuys WJ, Lockman PR, Allen DD, Van der Schyf CJ (2007) Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures. Neurochem Res 32:1686\u20131693","journal-title":"Neurochem Res"},{"key":"9309_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1196\/annals.1306.017","volume":"1012","author":"ME Gotz","year":"2004","unstructured":"Gotz ME, Double K, Gerlach M, Youdim MB, Riederer P (2004) The relevance of iron in the pathogenesis of Parkinson\u2019s disease. Ann N Y Acad Sci 1012:193\u2013208","journal-title":"Ann N Y Acad Sci"},{"key":"9309_CR14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(98)00669-1","volume":"91","author":"Y He","year":"1999","unstructured":"He Y, Lee T, Leong SK (1999) Time-course and localization of transferrin receptor expression in the substantia nigra of 6-hydroxydopamine-induced parkinsonian rats. Neuroscience 91:579\u2013585","journal-title":"Neuroscience"},{"key":"9309_CR15","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1471-4159.1992.tb08362.x","volume":"59","author":"K Jellinger","year":"1992","unstructured":"Jellinger K, Kienzl E, Rumpelmair G, Riederer P, Stachelberger H, Ben-Shachar D, Youdim MB (1992) Iron-melanin complex in substantia nigra of parkinsonian brains: an X-ray microanalysis. J Neurochem 59:1168\u20131171","journal-title":"J Neurochem"},{"key":"9309_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.neuint.2006.04.015","volume":"49","author":"H Jiang","year":"2006","unstructured":"Jiang H, Luan Z, Wang J, Xie J (2006) Neuroprotective effects of iron chelator desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int 49:605\u2013609","journal-title":"Neurochem Int"},{"key":"9309_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuint.2007.03.006","volume":"51","author":"H Jiang","year":"2007","unstructured":"Jiang H, Song N, Wang J, Ren LY, Xie JX (2007) Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. Neurochem Int 51:32\u201336","journal-title":"Neurochem Int"},{"key":"9309_CR18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(03)00353-3","volume":"2","author":"Y Ke","year":"2003","unstructured":"Ke Y, Ming Qian Z (2003) Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2:246\u2013253","journal-title":"Lancet Neurol"},{"key":"9309_CR19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-5-8","volume":"5","author":"JB Koprich","year":"2008","unstructured":"Koprich JB, Reske-Nielsen C, Mithal P, Isacson O (2008) Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease. J Neuroinflamm 5:8","journal-title":"J Neuroinflamm"},{"key":"9309_CR20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(96)00917-1","volume":"741","author":"A Kupsch","year":"1996","unstructured":"Kupsch A, Sautter J, Schwarz J, Riederer P, Gerlach M, Oertel WH (1996) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Brain Res 741:185\u2013196","journal-title":"Brain Res"},{"key":"9309_CR21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1022547819506","volume":"16","author":"R Legssyer","year":"2003","unstructured":"Legssyer R, Geisser P, McArdle H, Crichton RR, Ward RJ (2003) Comparison of injectable iron complexes in their ability to iron load tissues and to induce oxidative stress. Biometals 16:425\u2013433","journal-title":"Biometals"},{"key":"9309_CR22","doi-asserted-by":"crossref","first-page":"13905","DOI":"10.1074\/jbc.273.22.13905","volume":"273","author":"B Ligon","year":"1998","unstructured":"Ligon B, Boyd AE 3rd, Dunlap K (1998) Class A calcium channel variants in pancreatic islets and their role in insulin secretion. J Biol Chem 273:13905\u201313911","journal-title":"J Biol Chem"},{"key":"9309_CR23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/14737175.2.3.403","volume":"2","author":"GJ Linazasoro","year":"2002","unstructured":"Linazasoro GJ (2002) Neuroprotection in Parkinson\u2019s disease: love story or mission impossible? Expert Rev Neurother 2:403\u2013416","journal-title":"Expert Rev Neurother"},{"key":"9309_CR24","doi-asserted-by":"crossref","unstructured":"Lockman JA, Geldenhuys WJ, Bohn KA, Desilva SF, Allen DD, Van der Schyf CJ (2012) Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood\u2013brain barrier-associated cell types. Neurochem Res. doi: 10.1007\/s11064-011-0591-2","DOI":"10.1007\/s11064-011-0591-2"},{"key":"9309_CR25","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/WNR.0b013e32821c51fe","volume":"18","author":"ZG Ma","year":"2007","unstructured":"Ma ZG, Wang J, Jiang H, Liu TW, Xie JX (2007) Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats. Neuroreport 18:1181\u20131185","journal-title":"Neuroreport"},{"key":"9309_CR26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tips.2004.03.003","volume":"25","author":"W Meissner","year":"2004","unstructured":"Meissner W, Hill MP, Tison F, Gross CE, Bezard E (2004) Neuroprotective strategies for Parkinson\u2019s disease: conceptual limits of animal models and clinical trials. Trends Pharmacol Sci 25:249\u2013253","journal-title":"Trends Pharmacol Sci"},{"key":"9309_CR27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00702-005-0394-1","volume":"113","author":"R Moldzio","year":"2006","unstructured":"Moldzio R, Radad K, Duvigneau JC, Kranner B, Krewenka C, Piskernik C, Rausch WD (2006) Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture. J Neural Transm 113:1095\u20131105","journal-title":"J Neural Transm"},{"key":"9309_CR28","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","volume":"9","author":"GY Oudit","year":"2003","unstructured":"Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C, Yazdanpanah M, Wilson GJ, Schwartz A, Liu PP, Backx PH (2003) L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 9:1187\u20131194","journal-title":"Nat Med"},{"key":"9309_CR29","doi-asserted-by":"crossref","first-page":"31667","DOI":"10.1074\/jbc.M102613200","volume":"276","author":"R Peri","year":"2001","unstructured":"Peri R, Triggle DJ, Singh S (2001) Regulation of L-type calcium channels in pituitary GH(4)C(1) cells by depolarization. J Biol Chem 276:31667\u201331673","journal-title":"J Biol Chem"},{"key":"9309_CR30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1471-4914(00)01910-9","volume":"7","author":"ZM Qian","year":"2001","unstructured":"Qian ZM, Shen X (2001) Brain iron transport and neurodegeneration. Trends Mol Med 7:103\u2013108","journal-title":"Trends Mol Med"},{"key":"9309_CR31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/91036","volume":"28","author":"TA Rouault","year":"2001","unstructured":"Rouault TA (2001) Iron on the brain. Nat Genet 28:299\u2013300","journal-title":"Nat Genet"},{"key":"9309_CR32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF03033339","volume":"1","author":"HM Schipper","year":"1999","unstructured":"Schipper HM (1999) Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases. Neurotox Res 1:57\u201370","journal-title":"Neurotox Res"},{"key":"9309_CR33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/1389450043345209","volume":"5","author":"A Schurr","year":"2004","unstructured":"Schurr A (2004) Neuroprotection against ischemic\/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels. Curr Drug Targets 5:603\u2013618","journal-title":"Curr Drug Targets"},{"key":"9309_CR34","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","volume":"84","author":"RG Tsushima","year":"1999","unstructured":"Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PP, Backx PH (1999) Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ Res 84:1302\u20131309","journal-title":"Circ Res"},{"key":"9309_CR35","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/35069083","volume":"410","author":"SQ Wang","year":"2001","unstructured":"Wang SQ, Song LS, Lakatta EG, Cheng H (2001) Ca2+ signalling between single L-type Ca2+ channels and ryanodine receptors in heart cells. Nature 410:592\u2013596","journal-title":"Nature"},{"key":"9309_CR36","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11064-004-7031-5","volume":"29","author":"J Wang","year":"2004","unstructured":"Wang J, Jiang H, Xie JX (2004) Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system. Neurochem Res 29:2239\u20132243","journal-title":"Neurochem Res"},{"key":"9309_CR37","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuint.2007.10.019","volume":"52","author":"HM Xu","year":"2008","unstructured":"Xu HM, Jiang H, Wang J, Luo B, Xie JX (2008) Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells. Neurochem Int 52:1044\u20131051","journal-title":"Neurochem Int"},{"key":"9309_CR38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1196\/annals.1306.025","volume":"1012","author":"MB Youdim","year":"2004","unstructured":"Youdim MB, Stephenson G, Ben Shachar D (2004) Ironing iron out in Parkinson\u2019s disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann N Y Acad Sci 1012:306\u2013325","journal-title":"Ann N Y Acad Sci"},{"key":"9309_CR39","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1073\/pnas.0403495101","volume":"101","author":"L Zecca","year":"2004","unstructured":"Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, Giaveri G, Arosio P, Santambrogio P, Fariello RG, Karatekin E, Kleinman MH, Turro N, Hornykiewicz O, Zucca FA (2004a) The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci USA 101:9843\u20139848","journal-title":"Proc Natl Acad Sci USA"},{"key":"9309_CR40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrn1537","volume":"5","author":"L Zecca","year":"2004","unstructured":"Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004b) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863\u2013873","journal-title":"Nat Rev Neurosci"},{"key":"9309_CR41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/0264-6021:3490289","volume":"349","author":"L Zhang","year":"2000","unstructured":"Zhang L, Lee T, Wang Y, Soong TW (2000) Heterologous expression, functional characterization and localization of two isoforms of the monkey iron transporter Nramp2. Biochem J 349:289\u2013297","journal-title":"Biochem J"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-012-9309-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-012-9309-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-012-9309-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T13:31:21Z","timestamp":1559482281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-012-9309-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,19]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["9309"],"URL":"https:\/\/doi.org\/10.1007\/s12640-012-9309-8","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,19]]}}}